Latest Breaking News On - Marketing authorization - Page 1 : comparemela.com

Bulletin from the Annual General Meeting in Oncopeptides AB (publ)

Bulletin from the Annual General Meeting in Oncopeptides AB (publ)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomEuropean unionPeptide drug candidateMarketing authorizationNasdaq stockholm

PTC Therapeutics Announces Validation of Sepiapterin European MAA

- Review of European marketing application for PKU now initiated - WARREN, N.J., May 28, 2024 /PRNewswire/ PTC Therapeutics, Inc. announced today that the sepiapterin MAA for PKU has been.

Jeanine clementeKylie okeefeMatthewb kleinDrug administrationTherapeutics incEuropean medicines agencyChief executive officerMore informationPrivate securities litigation reform actQuarterly reportAnnual reportEuropean medicinesMarketing authorizationNew drug

Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomRussell trenaryJenene thomasEuropean commissionEuropean medicines agencyEuropean commission marketing authorizationRegulatory agencyOutlook therapeutics incCommittee on human medicinal productsInternational recognition procedureExchange commissionMarketing authorizationChief executive officerOutlook therapeuticsEnterprise strategy

Gilead Sciences, Inc : Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024

Key Findings from PBC, HDV, HCV, HBV and MASH/Fibrosis Studies Affirm Commitment to Drive Life-changing Science in Liver Disease - Gilead Sciences, Inc. (Nasdaq:GILD) today announced new research

Foster cityUnited statesFrank duffJacquie rossEpatitec mettiamociMeaghan smithGilead on twitter sciencesGilead sciences in liver diseaseGilead sciencesLove your liver campaignDrug administrationEuropean commissionGilead public affairsExchange commissionGilead sciences incWorld health organization

Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024

Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesFoster cityFrank duffEpatitec mettiamociGilead sciences in liver diseaseEuropean commissionGilead sciences incLove your liver campaignExchange commissionGilead sciencesDrug administrationWorld health organizationEuropean associationSenior vice presidentVirology therapeutic area headHepatitisc let